From: Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
Stem cell marker | Treatment modality | % Expression of positive cells (p value) |
---|---|---|
OCT4 | AZ | 63 ± 0.35 (p < 0.05) |
MS-275 | 37 ± 0.85 (p < 0.001) | |
AZ + MS-275 | 18 ± 0.45 (p < 0.05) | |
SOX2 | AZ | 68 ± 0.60 (p < 0.01) |
MS-275 | 39 ± 0.50 (p < 0.009) | |
AZ + MS-275 | 18 ± 0.46 (p < 0.002) | |
Nanog | AZ | 89 ± 0.60 (p < 0.01) |
MS-275 | 46 ± 0.45 (p < 0.01) | |
AZ + MS-275 | 30 ± 0.76 (p < 0.01) |